In other words, the x-axis positioning of the arrow running from cohort B to cohort C on the chart you posted in #msg-36349693 is not to be taken literally; all it signifies is that there’s a safety evaluation on patients in cohort B before cohort C can be commenced.
(As you can probably tell, I have not yet listened to ITMN’s Cowen webcast.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”